1,430 KRW
23.21 B KRW
97.10 B KRW
8.36 M
About NEOPHARM CO., LTD.
Sector
Industry
CEO
Yang-Soo Kim
Website
Headquarters
Daejeon
Founded
2000
ISIN
KR7092730001
FIGI
BBG000QLSRQ6
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of skin care products. It offers products for sensitive and dry skin, and the treatment of atopic dermatitis and psoriasis. Its brands include ATOPALM, Real Barrier, ZEROID, and Derma-B. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 092730 is 11,950 KRW — it has decreased by −1.00% in the past 24 hours. Watch NEOPHARM CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NEOPHARM CO., LTD. stocks are traded under the ticker 092730.
092730 stock has fallen by −0.67% compared to the previous week, the month change is a −2.47% fall, over the last year NEOPHARM CO., LTD. has showed a −2.05% decrease.
092730 reached its all-time high on Apr 11, 2018 with the price of 31,650 KRW, and its all-time low was 1,090 KRW and was reached on Oct 23, 2008. View more price dynamics on 092730 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
092730 stock is 1.86% volatile and has beta coefficient of 0.48. Track NEOPHARM CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is NEOPHARM CO., LTD. there?
Today NEOPHARM CO., LTD. has the market capitalization of 180.92 B, it has increased by 1.27% over the last week.
Yes, you can track NEOPHARM CO., LTD. financials in yearly and quarterly reports right on TradingView.
092730 net income for the last quarter is 4.34 B KRW, while the quarter before that showed 5.88 B KRW of net income which accounts for −26.30% change. Track more NEOPHARM CO., LTD. financial stats to get the full picture.
Yes, 092730 dividends are paid annually. The last dividend per share was 750.00 KRW. As of today, Dividend Yield (TTM)% is 3.16%. Tracking NEOPHARM CO., LTD. dividends might help you take more informed decisions.
NEOPHARM CO., LTD. dividend yield was 2.90% in 2023, and payout ratio reached 25.27%. The year before the numbers were 3.65% and 32.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 23, 2024, the company has 153.00 employees. See our rating of the largest employees — is NEOPHARM CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEOPHARM CO., LTD. EBITDA is 27.63 B KRW, and current EBITDA margin is 27.73%. See more stats in NEOPHARM CO., LTD. financial statements.
Like other stocks, 092730 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEOPHARM CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEOPHARM CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEOPHARM CO., LTD. stock shows the sell signal. See more of NEOPHARM CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.